Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (211-220 of 320) with videos related to

Pageof 32
Sort By:
Molecular Cancer Therapeutics|September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeYemin Wang, Shary Yuting Chen, Shane Colborne, et al.
The Journal of Pathology|June 2, 2012
Use of mutation profiles to refine the classification of endometrial carcinomasMelissa K McConechy, Jiarui Ding, Maggie Cu Cheang, et al.
Nature Communications|March 30, 2026
Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcomaFelix K F Kommoss, Joyce Yu Han Zhang, Branden J Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
The Journal of Pathology|September 9, 2020
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilitiesDane Cheasley, Abhimanyu Nigam, Magnus Zethoven, et al.
Nature Cancer|June 4, 2021
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinomaShuai Wu, Takeshi Fukumoto, Jianhuang Lin, et al.
Cancer Research|July 26, 2023
Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated CancerYemin Wang, Shary Yuting Chen, Monica Ta, et al.
Clinical Advances in Hematology & Oncology : H&O|June 19, 2012
The role of the fallopian tube in ovarian cancerAlicia A Tone, Shannon Salvador, Sarah J Finlayson, et al.
Gynecologic Oncology|March 16, 2016
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic typeLeora Witkowski, Catherine Goudie, Pilar Ramos, et al.
The Journal of Pathology. Clinical Research|January 11, 2021
Adult-type granulosa cell tumor of the ovary: a FOXL2-centric diseaseJessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, et al.
Pageof 32

Showing results (211-220 of 320) with videos related to

Sort By:
Pageof 32
Molecular Cancer Therapeutics|September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeYemin Wang, Shary Yuting Chen, Shane Colborne, et al.
The Journal of Pathology|June 2, 2012
Use of mutation profiles to refine the classification of endometrial carcinomasMelissa K McConechy, Jiarui Ding, Maggie Cu Cheang, et al.
Nature Communications|March 30, 2026
Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcomaFelix K F Kommoss, Joyce Yu Han Zhang, Branden J Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
The Journal of Pathology|September 9, 2020
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilitiesDane Cheasley, Abhimanyu Nigam, Magnus Zethoven, et al.
Nature Cancer|June 4, 2021
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinomaShuai Wu, Takeshi Fukumoto, Jianhuang Lin, et al.
Cancer Research|July 26, 2023
Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated CancerYemin Wang, Shary Yuting Chen, Monica Ta, et al.
Clinical Advances in Hematology & Oncology : H&O|June 19, 2012
The role of the fallopian tube in ovarian cancerAlicia A Tone, Shannon Salvador, Sarah J Finlayson, et al.
Gynecologic Oncology|March 16, 2016
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic typeLeora Witkowski, Catherine Goudie, Pilar Ramos, et al.
The Journal of Pathology. Clinical Research|January 11, 2021
Adult-type granulosa cell tumor of the ovary: a FOXL2-centric diseaseJessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, et al.
Pageof 32